AR013084A1 - Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados - Google Patents
Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionadosInfo
- Publication number
- AR013084A1 AR013084A1 ARP980102696A ARP980102696A AR013084A1 AR 013084 A1 AR013084 A1 AR 013084A1 AR P980102696 A ARP980102696 A AR P980102696A AR P980102696 A ARP980102696 A AR P980102696A AR 013084 A1 AR013084 A1 AR 013084A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- preparation
- compounds
- independently
- alkylene
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940122388 Thrombin inhibitor Drugs 0.000 title 1
- 150000001409 amidines Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003868 thrombin inhibitor Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000002947 alkylene group Chemical group 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- SYGWYBOJXOGMRU-UHFFFAOYSA-N chembl233051 Chemical compound C1=CC=C2C3=CC(C(N(CCN(C)C)C4=O)=O)=C5C4=CC=CC5=C3SC2=C1 SYGWYBOJXOGMRU-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un compuesto caracterizado porque comprende la formula (I), en la cual: R1 representa H, C1-4 alquilo (opcionalmente sustituido por uno o mássustituyentes seleccionados entre los siguientes: ciano, halo, OH, C(O)OR1a o C(O)N(R1b)(R1c) u OR1d; R1d representa H, C(O)R11, SiR12R13R14 o C1-6 alquilo,el ultimo grupo es opcionalmente sustituido por uno o más sustituyentes seleccionados entre los siguientes: OR15 o (CH2)qR16; R12, R13 y R14,independientemente el uno del otro, representa H, fenilo o C1-6 alquilo, R16 representa C1-4 alquilo, fenilo, OH, C(O)R17 o C(O)N(H)R18; R18 representaH, C1-4 alquilo o CH2C(O)OR19; R15 y R16, independientemente el uno del otro, representan H, C1-6 alquilo o C1-3 alquilfenilo; R1a, R1b, R1c, R11 y R19,independientemente el uno del otro, representan H o C1-4 alquilo; y q es un numero entero que vale, 0, 1 o 2; Rx representa un fragmento estructural de laformula IIa, IIb o IIc; en la cuales: las líneas de puntos, independientemente el uno del otro, representan dobles enlaces opcionales; A y B,independientemente el uno del otro, representan O o S, CH o CH2 (de acuerdo con necesidad), o N o N(R21) (de acuerdo con necesidad); D representa -CH2-,O, S, N(R22), -(CH2)2-, -CH=CH-, -CH2N(R22)-, -N(R22)CH2-, -CH=N-, -N=CH-, -CH2O-, -OCH2-, -CH2S- o -SCH2; X1 representa C2-4 alquileno, C2-3 alquilenointerrumpido por Z, -C(O)-Z-A1, -Z-C(O)-A1, -CH2-C(O)-A1, -Z-C(O)-Z-A2, -CH2-Z-C(O)-A2, -Z-CH2-C(O)-A2-, -Z-CH2-S(O)m-A2-, -CH2-Z-S(O)m-A2-, -C(O)-A3-,-Z-A3- o -A3-Z-; X2 representa C2-3 alquileno, -C(O)-A4- o A4-C(O)-; X3 representa CH o N; X4 representa un unico enlace, O, S, C(O), N(R23), -CH(R23)-, -CH(R23)-CH(R24)- o -C(R23)=C(R24)-; A representa un enlace simple o C1-2 alquileno; A2 representa un enlace simple o -CH2-; A3 representa C1-3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702378A SE9702378D0 (sv) | 1997-06-19 | 1997-06-19 | New compounds |
| SE9801099A SE9801099D0 (sv) | 1998-03-30 | 1998-03-30 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013084A1 true AR013084A1 (es) | 2000-12-13 |
Family
ID=26663014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102696A AR013084A1 (es) | 1997-06-19 | 1998-06-05 | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6265397B1 (es) |
| EP (1) | EP1012140B1 (es) |
| JP (2) | JP3919236B2 (es) |
| KR (1) | KR100540413B1 (es) |
| CN (1) | CN1205187C (es) |
| AR (1) | AR013084A1 (es) |
| AT (1) | ATE277902T1 (es) |
| AU (1) | AU737645C (es) |
| BR (1) | BR9810177A (es) |
| CA (1) | CA2294059C (es) |
| DE (1) | DE69826693T2 (es) |
| EE (1) | EE9900600A (es) |
| IL (1) | IL133490A0 (es) |
| IS (1) | IS5302A (es) |
| NO (1) | NO315156B1 (es) |
| NZ (1) | NZ501635A (es) |
| PL (1) | PL337645A1 (es) |
| SK (1) | SK167099A3 (es) |
| TR (1) | TR199903134T2 (es) |
| WO (1) | WO1998057932A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
| SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
| SE9804313D0 (sv) * | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
| CN1170842C (zh) | 1999-01-13 | 2004-10-13 | 阿斯特拉曾尼卡有限公司 | 新的脒基苄基胺衍生物及其作为凝血酶抑制剂的用途 |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
| SE0000382D0 (sv) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
| US6403818B1 (en) | 2000-02-28 | 2002-06-11 | Eisai Co., Ltd. | Process for producing α-hydroxy-carbonyl compound |
| SE0001803D0 (sv) * | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
| US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
| US7129233B2 (en) * | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| CN100350036C (zh) | 2001-04-27 | 2007-11-21 | 宝洁公司 | 用于控制生物膜的装置和方法 |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| CN101880277A (zh) | 2003-04-24 | 2010-11-10 | 因塞特公司 | 作为金属蛋白酶抑制剂的氮杂螺烷衍生物 |
| US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| ES2291951T3 (es) * | 2003-11-07 | 2008-03-01 | F. Hoffmann-La Roche Ag | Derivados de benzo (b) (1,4) dioxepina. |
| US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
| UA95788C2 (en) | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
| US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
| DE102008007440A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Aminosäurederivate als Arzneistoffe |
| KR20110025970A (ko) * | 2008-06-23 | 2011-03-14 | 아스트라제네카 아베 | 트롬빈 억제제로서 사용하기 위한 신규 복소환 카복스아미드 |
| CN104327029A (zh) * | 2014-09-21 | 2015-02-04 | 湖南华腾制药有限公司 | 一种含氧杂环化合物的制备方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
| HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
| CA1341029C (en) | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
| US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| EP0362002B1 (en) | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV protease inhibitors |
| ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
| TW201303B (es) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
| SE9102462D0 (sv) | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
| CZ333492A3 (en) | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
| SE9103612D0 (sv) | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
| JPH08501057A (ja) * | 1992-03-04 | 1996-02-06 | ヂョヂセルクタトー インテーゼット カーエフテー | 新規な抗凝結因子ペプチド誘導体及びそれを含有する製薬学的組成物及びその製造方法 |
| TW223629B (es) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
| US5583146A (en) | 1992-12-02 | 1996-12-10 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
| AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
| JPH06340619A (ja) | 1993-05-03 | 1994-12-13 | Bristol Myers Squibb Co | グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤 |
| SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| US5783563A (en) | 1993-06-03 | 1998-07-21 | Astra Aktiebolag | Method for treatment or prophylaxis of venous thrombosis |
| EP0648780A1 (en) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
| TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
| AU1025795A (en) | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
| ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5707966A (en) | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
| US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5726159A (en) | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
| US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
| DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
| DE4443390A1 (de) | 1994-12-06 | 1996-06-13 | Basf Ag | Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten |
| EA002767B1 (ru) | 1995-02-10 | 2002-08-29 | Басф Акциенгезельшафт | Ингибиторы тромбина |
| CZ245797A3 (cs) | 1995-02-17 | 1998-06-17 | Basf Aktiengesellschaft | Derivát amidinu dipeptidu jako inhibitor thrombinu |
| US5914319A (en) | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
| US5710130A (en) | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
| AU698911B2 (en) | 1995-04-04 | 1998-11-12 | Merck & Co., Inc. | Thrombin inhibitors |
| US5629324A (en) | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
| SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
| TWI238827B (en) | 1995-12-21 | 2005-09-01 | Astrazeneca Ab | Prodrugs of thrombin inhibitors |
| AU1990197A (en) | 1996-03-12 | 1997-10-01 | Bristol-Myers Squibb Company | Carbamyl guanidine and amidine prodrugs |
| SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
| JPH1095898A (ja) | 1996-09-25 | 1998-04-14 | Sumitomo Bakelite Co Ltd | 難燃性樹脂組成物およびこれを用いた積層板 |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
| DE19632772A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
| AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
-
1998
- 1998-06-05 AR ARP980102696A patent/AR013084A1/es not_active Application Discontinuation
- 1998-06-09 EP EP98929969A patent/EP1012140B1/en not_active Expired - Lifetime
- 1998-06-09 AU AU79461/98A patent/AU737645C/en not_active Ceased
- 1998-06-09 CN CNB988081172A patent/CN1205187C/zh not_active Expired - Fee Related
- 1998-06-09 JP JP50426299A patent/JP3919236B2/ja not_active Expired - Fee Related
- 1998-06-09 AT AT98929969T patent/ATE277902T1/de not_active IP Right Cessation
- 1998-06-09 DE DE69826693T patent/DE69826693T2/de not_active Expired - Fee Related
- 1998-06-09 EE EEP199900600A patent/EE9900600A/xx unknown
- 1998-06-09 NZ NZ501635A patent/NZ501635A/en unknown
- 1998-06-09 KR KR1019997012009A patent/KR100540413B1/ko not_active Expired - Fee Related
- 1998-06-09 CA CA002294059A patent/CA2294059C/en not_active Expired - Fee Related
- 1998-06-09 BR BR9810177-3A patent/BR9810177A/pt not_active Application Discontinuation
- 1998-06-09 IL IL13349098A patent/IL133490A0/xx not_active IP Right Cessation
- 1998-06-09 WO PCT/SE1998/001103 patent/WO1998057932A1/en not_active Ceased
- 1998-06-09 SK SK1670-99A patent/SK167099A3/sk unknown
- 1998-06-09 US US09/091,994 patent/US6265397B1/en not_active Expired - Fee Related
- 1998-06-09 PL PL98337645A patent/PL337645A1/xx not_active Application Discontinuation
- 1998-06-09 TR TR1999/03134T patent/TR199903134T2/xx unknown
-
1999
- 1999-12-15 IS IS5302A patent/IS5302A/is unknown
- 1999-12-17 NO NO19996313A patent/NO315156B1/no not_active IP Right Cessation
-
2001
- 2001-04-30 US US09/844,428 patent/US6576657B2/en not_active Expired - Fee Related
-
2006
- 2006-07-10 JP JP2006188906A patent/JP2006321807A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20020022612A1 (en) | 2002-02-21 |
| IL133490A0 (en) | 2001-04-30 |
| CA2294059A1 (en) | 1998-12-23 |
| AU737645C (en) | 2002-03-21 |
| SK167099A3 (en) | 2000-06-12 |
| AU7946198A (en) | 1999-01-04 |
| JP3919236B2 (ja) | 2007-05-23 |
| PL337645A1 (en) | 2000-08-28 |
| KR100540413B1 (ko) | 2006-01-12 |
| NO996313D0 (no) | 1999-12-17 |
| IS5302A (is) | 1999-12-15 |
| DE69826693T2 (de) | 2006-02-16 |
| TR199903134T2 (xx) | 2000-07-21 |
| BR9810177A (pt) | 2000-08-08 |
| CA2294059C (en) | 2008-12-09 |
| NO315156B1 (no) | 2003-07-21 |
| KR20010013982A (ko) | 2001-02-26 |
| JP2002503256A (ja) | 2002-01-29 |
| CN1205187C (zh) | 2005-06-08 |
| NO996313L (no) | 2000-02-21 |
| CN1266427A (zh) | 2000-09-13 |
| AU737645B2 (en) | 2001-08-23 |
| JP2006321807A (ja) | 2006-11-30 |
| ATE277902T1 (de) | 2004-10-15 |
| EE9900600A (et) | 2000-08-15 |
| DE69826693D1 (de) | 2004-11-04 |
| US6576657B2 (en) | 2003-06-10 |
| WO1998057932A1 (en) | 1998-12-23 |
| US6265397B1 (en) | 2001-07-24 |
| EP1012140B1 (en) | 2004-09-29 |
| EP1012140A1 (en) | 2000-06-28 |
| NZ501635A (en) | 2001-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013084A1 (es) | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados | |
| MXPA04007414A (es) | Indoles sustituidos como agonistas alfa-1. | |
| CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
| AR033306A1 (es) | Compuestos | |
| NO20051223L (no) | Oksadiazoler som modulatorer av metabotropisk glutamat reseptor-5. | |
| EA200200938A1 (ru) | Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение | |
| SE0302760D0 (sv) | New compounds | |
| PE20020084A1 (es) | N-(glicilo sustituido)-2-ciano-pirrolidinas como inhibidores de la dipeptidilpeptidasa-iv | |
| NO20051225L (no) | 1,2,4- oksadiazoler som modulatorer av metabotropisk glutamat-reseptor-5 | |
| AR037330A1 (es) | Derivado de quinazolina, composicion farmaceutica, su uso en la fabricacion de un medicamento y proceso para preparar dicho derivado de quinazolina | |
| AR048376A1 (es) | C- glicosidos heterociclos fusionados sustituidos | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| EA200200940A1 (ru) | Производные азетидина, способ их получения и содержащие их фармацевтические композиции | |
| MXPA03011244A (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6. | |
| AR036672A1 (es) | Derivados de pirrolidinona | |
| IS7965A (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
| CY1110904T1 (el) | Φαρμακευτικως ενεργα παραγωγα βενζοσουλφοναμιδιου ως αναστολεις πρωτεϊνικων κινασων jun | |
| NO324217B1 (no) | Kondenserte azepinderivater og deres anvendelse som antidiuretiske midler | |
| NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| CO5640109A2 (es) | Compuestos triciclicos inhibidores de la farnesisl proteino transferasa y composiciones farmaceuticas que los contienen | |
| AR052853A1 (es) | Composiciones orales que contienen compuestos antibacterianos de bifenol | |
| AR008543A1 (es) | Un compuesto de camptotecina, un medicamento, una composicion farmaceutica que lo comprende y el uso del compuesto. | |
| AR002741A1 (es) | Benciloxicarbonilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamentoque las contiene | |
| UY28688A1 (es) | Derivados de amida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |